# ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma

> **NCT00533169** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** ZD6474
- **DRUG:** Retinoic Acid

## Key facts

- **NCT ID:** NCT00533169
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Lack of enrollment.
- **Last updated:** 2011-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533169, "ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00533169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*